Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor. Dolsten’s ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

Pfizer (NYSE:PFE) announced Tuesday that its Chief Scientific Officer and President of Research & Development (R&D), Mikael ...

US pharmaceutical giant Pfizer on Tuesday said its chief scientific officer Mikael Dolsten, a key figure behind the ...

As Rocket Pharmaceuticals welcomes Dr. Mikael Dolsten from Pfizer to its Board of Directors, it's valuable to understand the financial health and market position of Pfizer (NYSE: PFE), where Dr ...

There were tears of joy and celebrations as the interim results of Pfizer’s new coronavirus vaccine were announced to employees, the company’s chief scientific officer said. Mikael Dolsten ...

Pfizer's recent financial performance shows 14% YoY operational growth excluding COVID sales. Check out more on PFE stock ...

"We're going to test that starting now in late January, when we're rolling out clinical trials comparing Omicron towards the current vaccine," Mikael Dolsten, Pfizer's chief scientific officer ...

The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

NEW YORK, July 09, 2024--Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and ...

Dr. Dolsten is an accomplished industry ... curing genetic disease,” said Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development. “I am excited to bring ...

As Rocket Pharmaceuticals welcomes Dr. Mikael Dolsten from Pfizer to its Board of Directors, it's valuable to understand the financial health and market position of Pfizer (NYSE: PFE), where Dr.